Human periosteum-derived cells from elderly patients as a source for cartilage tissue engineering?

Area of Science:

• Biomedical Engineering
• Regenerative Medicine
• Cell Biology

Background:

• Cartilage tissue engineering aims to regenerate damaged cartilage.
• Identifying suitable cell sources is crucial for successful cartilage regeneration.
• Human periosteum is a potential source, but its efficacy in elderly patients requires investigation.

Purpose of the Study:

• To evaluate the potential of human periosteum-derived cells from elderly patients for cartilage tissue engineering.
• To optimize culture conditions for enhancing proliferation and differentiation of these cells.
• To assess the chondrogenic capacity of periosteum-derived cells in vitro.

Main Methods:

• Periosteum was harvested from elderly patients (mean age 66).
• Cells were expanded in Minimum Essential Medium containing D-valine (MEM-DV) with supplements like Fibroblast Growth Factor-2 (FGF-2) and Insulin-like Growth Factor-1 (IGF-1).
• Chondrogenesis was induced using Transforming Growth Factor-beta (TGF-beta) isoforms and assessed via RT-PCR, immunohistochemistry, and Alcian blue staining.

Main Results:

• Periosteum-derived cells proliferated effectively in MEM-DV supplemented with FGF-2 and non-essential amino acids.
• Chondrogenesis was observed in 59% of samples with single TGF-beta isoforms and 83% with dual TGF-beta isoforms.
• Histological and molecular analyses confirmed the expression of cartilage-specific markers.

Conclusions:

• Human periosteum from elderly individuals possesses significant chondrogenic potential.
• Optimized culture media, particularly with dual TGF-beta isoforms, enhance chondrogenesis.
• Periosteum-derived cells represent a viable and attractive cell source for cartilage tissue engineering applications in older populations.